← Eichor
Condition: Craniopharyngioma Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Craniopharyngioma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults
Phase 2 · 20 location(s) · Sabine Mueller, MD, PhD · NCT05465174Efficacy and Safety of Phentermine/Topiramate in Youth With Hypothalamic Obesity
Phase 2 · 2 location(s) · Seattle Children's Hospital · NCT06299891ImmunoPET Targeting Trophoblast Cell-surface Antigen 2 (Trop-2) in Craniopharyngioma Patients
NA · 1 location(s) · Deling Li · NCT07177482ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
Phase 2 · 14 location(s) · Nationwide Children's Hospital · NCT05233397Safety and Efficacy of Anlotinib in the Treatment of Recurrent Craniopharyngioma
Phase 1/Phase 2 · 1 location(s) · Nanfang Hospital, Southern Medical University · NCT06970145MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
Phase 2 · 10 location(s) · Nationwide Children's Hospital · NCT05286788Craniopharyngioma and Pregnancies
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06801756Treatment of BRAF ( B-Rapidly Accelerated Fibrosarcoma) Mutated Papillary Craniopharyngioma
Phase 2 · 1 location(s) · Eva Marie Erfurth, MD, PhD · NCT05525273Clinical Trial of an Anti-Fog Drainage Device for Endoscopic Endonasal Sellar Region Tumor Surgery
NA · 1 location(s) · West China Hospital · NCT07316101The Impact of Endoscopic Endonasal Skull Base Surgery on Olfaction
Phase N/A · 3 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT0687442690Yttrium Colloid for the Treatment of Cystic Sellar/Parasellar Tumors
Phase 3 · 1 location(s) · David Clarke · NCT02081768Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology
Phase N/A · 3 location(s) · Maastricht Radiation Oncology · NCT04648462FOG-001 in Locally Advanced or Metastatic Solid Tumors
Phase 1/Phase 2 · 33 location(s) · Parabilis Medicines, Inc. · NCT05919264
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.